222 related articles for article (PubMed ID: 34676685)
21. Comparison of the cachexia index based on hand-grip strength (H-CXI) with the original CXI for the prediction of cancer cachexia and prognosis in patients who underwent radical colectomy for colorectal cancer.
Yan XL; Wu LM; Tang XB; Li ZZ; Zhang Z; Jiang HJ; Chen ZT; Chen DH; Li JY; Shen X; Huang DD
Front Nutr; 2024; 11():1290299. PubMed ID: 38445206
[TBL] [Abstract][Full Text] [Related]
22. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Itabashi M; Ishibashi D; Yamamoto E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Hattori Y; Motohashi K; Takasaki H; Ohshima R; Hashimoto C; Yamazaki E; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
Eur J Haematol; 2014 Mar; 92(3):204-10. PubMed ID: 24283206
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of cachexia index in patients with hepatocellular carcinoma after hepatic resection.
Akaoka M; Haruki K; Taniai T; Yanagaki M; Igarashi Y; Furukawa K; Onda S; Tsunematsu M; Shirai Y; Okui N; Gocho T; Ikegami T
Surg Oncol; 2022 Dec; 45():101881. PubMed ID: 36371905
[TBL] [Abstract][Full Text] [Related]
24. Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.
Molina TJ; Canioni D; Copie-Bergman C; Recher C; Brière J; Haioun C; Berger F; Fermé C; Copin MC; Casasnovas O; Thieblemont C; Petrella T; Leroy K; Salles G; Fabiani B; Morschauser F; Mounier N; Coiffier B; Jardin F; Gaulard P; Jais JP; Tilly H
J Clin Oncol; 2014 Dec; 32(35):3996-4003. PubMed ID: 25385729
[TBL] [Abstract][Full Text] [Related]
25. Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma.
Nakamura N; Hara T; Shibata Y; Matsumoto T; Nakamura H; Ninomiya S; Kito Y; Kitagawa J; Kanemura N; Goto N; Shiraki M; Miyazaki T; Takeuchi T; Shimizu M; Tsurumi H
Ann Hematol; 2015 Dec; 94(12):2043-53. PubMed ID: 26385388
[TBL] [Abstract][Full Text] [Related]
26. Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
Brown LR; Thomson GG; Gardner E; Chien S; McGovern J; Dolan RD; McSorley ST; Forshaw MJ; McMillan DC; Wigmore SJ; Crumley AB; Skipworth RJE
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38593042
[TBL] [Abstract][Full Text] [Related]
27. Impact of cachexia on outcomes in aggressive lymphomas.
Karmali R; Alrifai T; Fughhi IAM; Ng R; Chukkapalli V; Shah P; Basu S; Nathan S; Szymanski-Grant K; Gordon LI; Venugopal P; Penedo FJ; Borgia JA
Ann Hematol; 2017 Jun; 96(6):951-956. PubMed ID: 28417157
[TBL] [Abstract][Full Text] [Related]
28. A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.
Miura K; Konishi J; Miyake T; Makita M; Hojo A; Masaki Y; Uno M; Ozaki J; Yoshida C; Niiya D; Kitazume K; Maeda Y; Takizawa J; Sakai R; Yano T; Yamamoto K; Sunami K; Hiramatsu Y; Aoyama K; Tsujimura H; Murakami J; Hatta Y; Kanno M
Oncologist; 2017 May; 22(5):554-560. PubMed ID: 28408622
[TBL] [Abstract][Full Text] [Related]
29. Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP.
Shin DY; Kim A; Byun BH; Moon H; Kim S; Ko YJ; Kim MJ; Lee HR; Kang HJ; Na II; Park S; Lee SS; Yang SH
Ann Hematol; 2016 Feb; 95(3):409-16. PubMed ID: 26658607
[TBL] [Abstract][Full Text] [Related]
30. Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.
Delarue R; Tilly H; Mounier N; Petrella T; Salles G; Thieblemont C; Bologna S; Ghesquières H; Hacini M; Fruchart C; Ysebaert L; Fermé C; Casasnovas O; Van Hoof A; Thyss A; Delmer A; Fitoussi O; Molina TJ; Haioun C; Bosly A
Lancet Oncol; 2013 May; 14(6):525-33. PubMed ID: 23578722
[TBL] [Abstract][Full Text] [Related]
31. Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy.
Hong J; Woo HS; Kim H; Ahn HK; Sym SJ; Park J; Ahn JY; Cho EK; Shin DB; Lee JH
Cancer Sci; 2014 Dec; 105(12):1569-75. PubMed ID: 25263825
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy.
Goh MJ; Kang W; Jeong WK; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Sci Rep; 2022 May; 12(1):7647. PubMed ID: 35538112
[TBL] [Abstract][Full Text] [Related]
33. Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP.
Zhou Q; Wei Y; Huang F; Wei X; Wei Q; Hao X; Zhang Y; Feng R
Int J Hematol; 2016 Oct; 104(4):485-90. PubMed ID: 27393279
[TBL] [Abstract][Full Text] [Related]
34. Cachexia Index as a Prognostic Indicator in Patients with Gastric Cancer: A Retrospective Study.
Gong C; Wan Q; Zhao R; Zuo X; Chen Y; Li T
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139560
[TBL] [Abstract][Full Text] [Related]
35. Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP.
Wang Y; Li YJ; Jiang WQ; Rao HL; Huang JJ; Xia Y; Bi X; Sun P; Huang HQ; Lin TY; Guan ZZ; Li ZM
Ann Hematol; 2015 Nov; 94(11):1865-73. PubMed ID: 26327569
[TBL] [Abstract][Full Text] [Related]
36. Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.
Shustik J; Han G; Farinha P; Johnson NA; Ben Neriah S; Connors JM; Sehn LH; Horsman DE; Gascoyne RD; Steidl C
Haematologica; 2010 Jan; 95(1):96-101. PubMed ID: 19797725
[TBL] [Abstract][Full Text] [Related]
37. Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma.
Niiyama-Uchibori Y; Okamoto H; Miyashita A; Mizuhara K; Kanayama-Kawaji Y; Fujino T; Tsukamoto T; Mizutani S; Shimura Y; Teramukai S; Kuroda J
Hematol Oncol; 2024 Jan; 42(1):e3252. PubMed ID: 38287527
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Significance of the Cachexia Index in Patients with Non-Small-Cell Lung Cancer and Brain Metastases after Stereotactic Radiotherapy.
Xu H; Zhang B; Zhang Y; Yang C; Bo C; Guo Y; Cheng Y; He L
Clin Med Insights Oncol; 2024; 18():11795549231222362. PubMed ID: 38440045
[TBL] [Abstract][Full Text] [Related]
39. Hand grip strength-based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer.
Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Gan J; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):382-390. PubMed ID: 36447437
[TBL] [Abstract][Full Text] [Related]
40. A new prognostic model using the NCCN-IPI and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma.
Go SI; Park S; Kim JH; Kim HR; Kim M; Moon K; Seo J; Lee GW
Tumori; 2018 Aug; 104(4):292-299. PubMed ID: 29737944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
